Characteristics | Total | Recurrence | No recurrence | P-value |
---|---|---|---|---|
(n = 353) | (n = 85) | (n = 268) | ||
General clinical characteristic | ||||
Age (years) | 61.56 ± 9.47 | 61.87 ± 9.49 | 61.46 ± 9.47 | 0.643 |
Sex | Â | Â | Â | 0.306 |
 Male | 199 (56.4) | 52 (61.2) | 147 (54.9) |  |
 Female | 154 (43.6) | 33 (38.8) | 121 (45.1) |  |
BMI (kg/m2) | 24.79 ± 3.09 | 24.83 ± 3.14 | 24.77 ± 3.08 | 0.867 |
SBP (mmHg) | 128.10 ± 15.37 | 127.94 ± 14.46 | 128.15 ± 15.68 | 0.912 |
DBP (mmHg) | 79.18 ± 10.33 | 79.78 ± 9.93 | 78.99 ± 10.47 | 0.541 |
Type of AF |  |  |  | < 0.001 |
 Paroxysmal | 257 (72.8) | 48 (56.5) | 209 (78.0) |  |
 Persistent | 96 (27.2) | 37 (43.5) | 59 (22.0) |  |
AF duration (months) | 25.26 ± 36.68 | 29.12 ± 33.32 | 24.03 ± 37.66 | 0.045 |
CHADS2 score | 0.90 ± 0.93 | 1.04 ± 1.06 | 0.86 ± 0.88 | 0.288 |
CHA2DS2-VASc score | 1.78 ± 1.37 | 1.89 ± 1.47 | 1.75 ± 1.34 | 0.443 |
Comorbidity | ||||
Hypertension | 208 (58.9) | 53 (62.4) | 155 (57.8) | 0.461 |
Diabetes | 34 (9.6) | 12 (14.1) | 22 (8.2) | 0.108 |
Dyslipidemia | 18 (5.1) | 6 (7.1) | 12 (4.5) | 0.509 |
Stroke/TIA | 21 (5.9) | 6 (7.1) | 15 (5.6) | 0.620 |
Hematological index | ||||
Hemoglobin (g/L) | 138.70 ± 16.19 | 140.24 ± 15.02 | 138.21 ± 16.54 | 0.316 |
FBG (mmol/L) | 5.07 ± 0.82 | 5.13 ± 0.99 | 5.06 ± 0.76 | 0.925 |
Sc (μmol/L) | 70.10 ± 15.60 | 73.94 ± 20.37 | 68.88 ± 13.55 | 0.163 |
UA (μmol/L) | 347.16 ± 88.31 | 355.63 ± 92.40 | 344.46 ± 86.97 | 0.311 |
ALB (g/L) | 42.32 ± 3.43 | 42.48 ± 3.89 | 42.28 ± 3.28 | 0.637 |
TC (mmol/L) | 4.41 ± 0.95 | 4.26 ± 1.05 | 4.45 ± 0.91 | 0.111 |
TG (mmol/L) | 1.62 ± 1.09 | 1.71 ± 1.11 | 1.59 ± 1.08 | 0.252 |
LDL-C (mmol/L) | 2.56 ± 0.83 | 2.40 ± 0.80 | 2.61 ± 0.83 | 0.126 |
HDL-C (mmol/L) | 1.15 ± 0.29 | 1.12 ± 0.32 | 1.16 ± 0.28 | 0.177 |
Echocardiographic parameter | ||||
LAD (mm) | 42.48 ± 5.50 | 44.68 ± 5.18 | 41.77 ± 5.42 | < 0.001 |
LVEF (%) | 62.84 ± 5.48 | 61.92 ± 5.14 | 63.13 ± 5.56 | 0.076 |
LVEDD (mm) | 48.72 ± 4.46 | 49.02 ± 5.01 | 48.63 ± 4.27 | 0.510 |
LVESD (mm) | 32.03 ± 4.01 | 32.40 ± 3.97 | 31.91 ± 4.02 | 0.331 |
Ablation procedure | Â | Â | Â | 0.453 |
CPVI alone | 232 (65.7) | 53 (62.4) | 179 (66.8) | Â |
CPVI plus additional ablation | 121 (34.3) | 32 (37.6) | 89 (33.2) | Â |
Direct current cardioversion | 103 (29.2) | 37 (43.5) | 66 (24.6) | 0.001 |
Medication | ||||
Oral anticoagulant | Â | Â | Â | 0.295 |
 Warfarin | 25 (7.1) | 9 (10.6) | 16 (6.0) |  |
 Dabigatran | 255 (72.2) | 61 (71.8) | 194 (72.4) |  |
 Rivaroxaban | 73 (20.7) | 15 (17.6) | 58 (21.6) |  |
ACEI/ARB | 145 (41.1) | 41 (48.2) | 104 (38.8) | 0.124 |
β-Blocker | 165 (46.7) | 45 (52.9) | 120 (44.8) | 0.189 |
Amiodarone | 249 (70.5) | 62 (72.9) | 187 (69.8) | 0.577 |
Propafenone | 52 (14.7) | 15 (17.6) | 37 (13.8) | 0.384 |
Biomarkers | ||||
hs-CRP (mg/L) | 1.97 ± 2.58 | 2.76 ± 3.45 | 1.71 ± 2.18 | 0.004 |
CA-125 (U/mL) | 13.06 ± 8.38 | 18.71 ± 12.63 | 11.27 ± 5.40 | < 0.001 |